Pairing of oligosaccharides in the Fc region of immunoglobulin G. 2000

K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
Suntory Institute for Bioorganic Research, Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka, Japan. katsuyoshi_masuda@suntory.co.jp

The Fc portion of immunoglobulin G (IgG) expresses paired oligosaccharides with microheterogeneities, which are associated with efficiencies of effector functions and with pathological states. A comparison of electrospray ionization mass spectrometry data obtained using a variety of Fc fragments derived from human and mouse IgG that do and do not retain the inter-chain disulfide bridge(s) revealed that (1) the Fc portion can be asymmetric as well as symmetric with respect to glycosylation and (2) the ratios of the individual glycoforms are different from what is expected from the random pairing.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007141 Immunoglobulin Fc Fragments Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fc Fragment,Fc Fragments,Fc Immunoglobulin,Fc Immunoglobulins,Ig Fc Fragments,Immunoglobulin Fc Fragment,Immunoglobulins, Fc,Immunoglobulins, Fc Fragment,Fc Fragment Immunoglobulins,Fc Fragment, Immunoglobulin,Fc Fragments, Ig,Fc Fragments, Immunoglobulin,Fragment Immunoglobulins, Fc,Fragment, Fc,Fragments, Ig Fc,Immunoglobulin, Fc
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D005260 Female Females

Related Publications

K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
February 1996, Cancer biotherapy & radiopharmaceuticals,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
January 1985, Annales de l'Institut Pasteur. Immunologie,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
January 2014, Central-European journal of immunology,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
August 2018, Bioconjugate chemistry,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
January 2008, Nucleic acids symposium series (2004),
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
April 1972, Biochemical and biophysical research communications,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
October 2005, Nature biotechnology,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
January 1983, Biochemical and biophysical research communications,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
December 1968, Proceedings of the National Academy of Sciences of the United States of America,
K Masuda, and Y Yamaguchi, and K Kato, and N Takahashi, and I Shimada, and Y Arata
May 1976, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!